ACAD logo

ACADIA Pharmaceuticals (ACAD) Retained Earnings

Annual Retained Earnings

-$2.43 B
-$61.29 M-2.59%

December 31, 2023


Summary


Performance

ACAD Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Quarterly Retained Earnings

-$2.35 B
+$32.77 M+1.38%

September 30, 2024


Summary


Performance

ACAD Quarterly Retained Earnings Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherACADbalance sheetmetrics:

Retained Earnings Formula

Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid

ACAD Retained Earnings Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-2.6%+5.2%
3 y3 years-22.4%-11.3%
5 y5 years-65.5%-42.2%

ACAD Retained Earnings Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-12.9%at low-9.0%+5.2%
5 y5-year-42.6%at low-37.8%+5.2%
alltimeall time-4378.9%at low-3334.7%+5.2%

ACADIA Pharmaceuticals Retained Earnings History

DateAnnualQuarterly
Sep 2024
-
-$2.35 B(-1.4%)
Jun 2024
-
-$2.38 B(-1.4%)
Mar 2024
-
-$2.41 B(-0.7%)
Dec 2023
-$2.43 B(+2.6%)
-$2.43 B(-1.8%)
Sep 2023
-
-$2.48 B(+2.7%)
Jun 2023
-
-$2.41 B(-0.0%)
Mar 2023
-
-$2.41 B(+1.8%)
Dec 2022
-$2.37 B(+10.0%)
-$2.37 B(+1.8%)
Sep 2022
-
-$2.33 B(+1.2%)
Jun 2022
-
-$2.30 B(+1.5%)
Mar 2022
-
-$2.27 B(+5.2%)
Dec 2021
-$2.15 B(+8.5%)
-$2.15 B(+2.0%)
Sep 2021
-
-$2.11 B(+0.7%)
Jun 2021
-
-$2.10 B(+2.1%)
Mar 2021
-
-$2.05 B(+3.3%)
Dec 2020
-$1.99 B(+16.5%)
-$1.99 B(+3.5%)
Sep 2020
-
-$1.92 B(+4.6%)
Jun 2020
-
-$1.83 B(+2.4%)
Mar 2020
-
-$1.79 B(+5.2%)
Dec 2019
-$1.70 B(+16.0%)
-$1.70 B(+3.2%)
Sep 2019
-
-$1.65 B(+2.6%)
Jun 2019
-
-$1.61 B(+3.5%)
Mar 2019
-
-$1.55 B(+5.8%)
Dec 2018
-$1.47 B(+20.0%)
-$1.47 B(+4.7%)
Sep 2018
-
-$1.40 B(+4.6%)
Jun 2018
-
-$1.34 B(+5.0%)
Mar 2018
-
-$1.28 B(+4.4%)
Dec 2017
-$1.22 B(+31.0%)
-$1.22 B(+6.0%)
Sep 2017
-
-$1.15 B(+6.0%)
Jun 2017
-
-$1.09 B(+6.6%)
Mar 2017
-
-$1.02 B(+9.4%)
Dec 2016
-$933.98 M(+41.0%)
-$933.98 M(+9.2%)
Sep 2016
-
-$855.28 M(+9.1%)
Jun 2016
-
-$783.67 M(+10.0%)
Mar 2016
-
-$712.35 M(+7.5%)
Dec 2015
-$662.59 M(+33.0%)
-$662.59 M(+7.4%)
Sep 2015
-
-$616.80 M(+6.7%)
Jun 2015
-
-$577.90 M(+7.3%)
Mar 2015
-
-$538.52 M(+8.1%)
Dec 2014
-$498.14 M
-$498.14 M(+6.0%)
Sep 2014
-
-$469.78 M(+5.6%)
Jun 2014
-
-$444.99 M(+5.1%)
DateAnnualQuarterly
Mar 2014
-
-$423.50 M(+4.4%)
Dec 2013
-$405.67 M(+10.3%)
-$405.67 M(+3.1%)
Sep 2013
-
-$393.62 M(+2.8%)
Jun 2013
-
-$382.92 M(+2.4%)
Mar 2013
-
-$373.84 M(+1.7%)
Dec 2012
-$367.72 M(+6.0%)
-$367.72 M(+1.9%)
Sep 2012
-
-$360.91 M(+0.7%)
Jun 2012
-
-$358.51 M(+1.5%)
Mar 2012
-
-$353.09 M(+1.8%)
Dec 2011
-$346.87 M(+7.0%)
-$346.87 M(+1.6%)
Sep 2011
-
-$341.57 M(+1.5%)
Jun 2011
-
-$336.50 M(+2.0%)
Mar 2011
-
-$329.94 M(+1.8%)
Dec 2010
-$324.11 M(-4.5%)
-$324.11 M(-8.2%)
Sep 2010
-
-$353.25 M(+1.2%)
Jun 2010
-
-$349.02 M(+1.2%)
Mar 2010
-
-$344.73 M(+1.6%)
Dec 2009
-$339.25 M(+15.4%)
-$339.25 M(+2.6%)
Sep 2009
-
-$330.56 M(+2.7%)
Jun 2009
-
-$321.83 M(+4.1%)
Mar 2009
-
-$309.10 M(+5.1%)
Dec 2008
-$294.10 M(+27.9%)
-$294.10 M(+5.0%)
Sep 2008
-
-$280.14 M(+5.9%)
Jun 2008
-
-$264.52 M(+7.4%)
Mar 2008
-
-$246.24 M(+7.1%)
Dec 2007
-$229.86 M(+32.5%)
-$229.86 M(+8.0%)
Sep 2007
-
-$212.82 M(+8.2%)
Jun 2007
-
-$196.77 M(+5.8%)
Mar 2007
-
-$186.02 M(+7.2%)
Dec 2006
-$173.47 M(+35.1%)
-$173.47 M(+7.7%)
Sep 2006
-
-$161.02 M(+7.5%)
Jun 2006
-
-$149.75 M(+8.6%)
Mar 2006
-
-$137.88 M(+7.4%)
Dec 2005
-$128.42 M(+36.2%)
-$128.42 M(+8.6%)
Sep 2005
-
-$118.22 M(+11.6%)
Jun 2005
-
-$105.91 M(+6.0%)
Mar 2005
-
-$99.87 M(+5.9%)
Dec 2004
-$94.28 M(+37.9%)
-$94.28 M(+8.4%)
Sep 2004
-
-$86.95 M(+7.7%)
Jun 2004
-
-$80.73 M(+7.9%)
Mar 2004
-
-$74.85 M(+9.5%)
Dec 2003
-$68.37 M(+26.0%)
-$68.37 M
Dec 2002
-$54.27 M
-

FAQ

  • What is ACADIA Pharmaceuticals annual retained earnings?
  • What is the all time high annual retained earnings for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals annual retained earnings year-on-year change?
  • What is ACADIA Pharmaceuticals quarterly retained earnings?
  • What is the all time high quarterly retained earnings for ACADIA Pharmaceuticals?
  • What is ACADIA Pharmaceuticals quarterly retained earnings year-on-year change?

What is ACADIA Pharmaceuticals annual retained earnings?

The current annual retained earnings of ACAD is -$2.43 B

What is the all time high annual retained earnings for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high annual retained earnings is -$54.27 M

What is ACADIA Pharmaceuticals annual retained earnings year-on-year change?

Over the past year, ACAD annual retained earnings has changed by -$61.29 M (-2.59%)

What is ACADIA Pharmaceuticals quarterly retained earnings?

The current quarterly retained earnings of ACAD is -$2.35 B

What is the all time high quarterly retained earnings for ACADIA Pharmaceuticals?

ACADIA Pharmaceuticals all-time high quarterly retained earnings is -$68.37 M

What is ACADIA Pharmaceuticals quarterly retained earnings year-on-year change?

Over the past year, ACAD quarterly retained earnings has changed by +$128.51 M (+5.19%)